Alumis (ALMS) Accumulated Expenses (2023 - 2025)
Alumis (ALMS) reported Accumulated Expenses of $34.8 million for Q4 2025, up 19.32% year-over-year from $29.1 million in Q4 2024, and down 7.57% quarter-over-quarter from $37.6 million in Q3 2025.
Alumis (ALMS) Accumulated Expenses (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Accumulated Expenses data on file, last reported at $34.8 million in Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $34.8 million, up 19.32% year-over-year; the trailing twelve-month figure through Dec 2025 was $34.8 million (up 19.32% YoY), and the FY2025 annual result was $34.8 million, up 19.32% from the prior year.
- Accumulated Expenses slipped to $34.8 million in Q4 2025 per ALMS's latest filing, from $37.6 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $37.6 million in Q3 2025 and troughed at $3.7 million in Q1 2025.
- A 3-year average of $19.2 million and a median of $16.4 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses jumped 421.92% in 2024, then plunged 32.49% in 2025.
- A 3-year view of Accumulated Expenses shows it stood at $5.6 million in 2023, then jumped by 421.92% to $29.1 million in 2024, then increased by 19.32% to $34.8 million in 2025.
- Business Quant data shows ALMS's Accumulated Expenses at $34.8 million in Q4 2025, $37.6 million in Q3 2025, and $9.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.78 Mn |
| Sep 30, 2025 | 37.63 Mn |
| Jun 30, 2025 | 9.85 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 29.15 Mn |
| Sep 30, 2024 | 18.14 Mn |
| Jun 30, 2024 | 14.58 Mn |
| Dec 31, 2023 | 5.59 Mn |